Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8⁺ T Cells for the Treatment of Patients With Metastatic Melanoma

This publication has 25 references indexed in Scilit:

• Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma
  Journal of Clinical Oncology, 2005
• Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus+ Hodgkin's Disease
  The Journal of Experimental Medicine, 2004
• Adoptive T cell therapy using antigen-specific CD8⁺T cell clones for the treatment of patients with metastatic melanoma:In vivopersistence, migration, and antitumor effect of transferred T cells
  Proceedings of the National Academy of Sciences, 2002
• T cell defined tumor antigens
  Current Opinion in Immunology, 1997
• Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
  New England Journal of Medicine, 1995
• A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
  The Journal of Experimental Medicine, 1994
• Infusions of Donor Leukocytes to Treat Epstein-Barr Virus-Associated Lymphoproliferative Disorders after Allogeneic Bone Marrow Transplantation
  New England Journal of Medicine, 1994
• Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
  Proceedings of the National Academy of Sciences, 1994
• Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
  Blood, 1990
• "Anomalous" THY-1(+) killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytes
  The Journal of Experimental Medicine, 1982